Intrapericardial Ibutilide Administration Fails to Terminate Pacing-Induced Sustained Atrial Fibrillation in Dogs
Authors: András Vereckei1; J. Cristopher Gorski2; Michael Ujhelyi3; Rahul Mehra3; Douglas P. Zipes4
Source: Cardiovascular Drugs and Therapy, Volume 18, Number 4, July 2004 , pp. 269-277(9)
Publisher: Springer
Abstract:
Purpose: The hypothesis that intrapericardial (ip.) ibutilide administration would terminate pacing-induced sustained atrial fibrillation (AF) and ibutilide distribution were tested.Methods and results: Sustained (
24 hours) AF was induced by 59 ± 20 day rapid atrial pacing in 19 dogs. After sustained AF was present, the atrial pacemaker was turned off and 9 open chest dogs received 0.015 mg/kg ibutilide (37° C) in 30 ml saline into the pericardial sac. Ten control dogs received 30 ml saline (37° C) ip. QT intervals, right ventricular monophasic action potential duration at 90% of repolarization (RV-MAPD90), AF mean cycle length (AFCLm), systolic- and diastolic intraarterial blood pressures, intrapericardial-, right atrial- and ventricular pressures, cardiac output and ibutilide concentrations were measured. If AF persisted after the 1st drug infusion, dual site rapid atrial pacing (DRAP) simultaneously from the high right atrium and coronary sinus was performed to terminate AF. If it was ineffective, a 2nd ip. drug infusion in the same fashion as the 1st one, was attempted. There was no significant difference in AF termination [5/9 (56%) in ibutilide treated and 3/10 (30%) in control dogs] between the two groups. DRAP never terminated AF. The AF duration did not differ between the two groups. Compared with control, ibutilide treatment prolonged significantly AFCLm (p < 0.001) and non-significantly QT, RV-MAPD90. No significant difference was found in systolic and diastolic blood pressure and cardiac output between the two groups. The two orders of magnitude greater ibutilide concentration in the pericardial fluid than that in the femoral vein decreased rapidly over time, drug concentration was greatest in the atria, smaller in the ventricular myocardium, with a trend decreasing from the epi- to endocardium.Conclusions: Despite a significant atrial electrophysiological effect, ip. delivery of ibutilide did not result in higher AF termination rate compared with control.
Keywords: intrapericardial administration; ibutilide; atrial fibrillation
Document Type: Research article
DOI: 10.1023/B:CARD.0000041246.13952.b4
Affiliations: 1: 3rd Department of Medicine, Semmelweis University, School of Medicine, Budapest., Email: vereckei@kut.sote.hu 2: Indiana University, Department of Medicine, Clinical Pharmacology Division, Indianapolis, Indiana 3: Medtronic Inc., Minneapolis, Minnesota 4: Department of Medicine, The Krannert Institute of Cardiology, Indiana University School of Medicine, Indianapolis, Indiana

Click here for Page Help